HTRS Mid-Career Research Award

The 2021 HTRS Mid-Career Research Award (MCRA): Deadline Passed

Letters of Intent are currently under review for the 2021 HTRS Mid-Career Research Award (MCRA).  Select applicants have been invited to submit Full Proposals, due July 26, 2021.  The 2021 MCRA recipient will be announced in November 2021. 

Please see the 2021 Request for Proposals (RFP) for general eligiblity requirements and submission guidelines.  Questions should be directed to Terri Holzen in the HTRS office at [email protected] or by calling (414) 937-6569

The HTRS Mid-Career Research Award (MCRA) Program provides financial support for mid-career investigators pursuing clinical, translational, or basic science research projects in hemostasis and/or thrombosis. Applicants must be working in the United States or Canada for the duration of the proposed project.  The project funded by this program will run for two years: November 2021 - October 2023.  

The goals of the MCRA Program are to:

  1. Advance the science underlying the clinical management of hemostasis and thrombosis by supporting investigator-initiated research to ultimately improve the health and well-being of people living with blood disorders
  2. Provide financial support for talented mid-career physician-scientists to enable them to transition from mentored research to full research independence
  3. Combat the shortage of skilled academic researchers in benign hematology by supporting mid-career physician-scientists in the U.S. and Canada at a critical juncture in their academic research careers. Upon the completion of a project funded by the MCRA Program, the recipient should be ready to apply for a large-scale grant to expand their research in hemostasis and/or thrombosis such as an NIH R01, NIH R34, or the equivalent from another agency such as the Canadian Institutes of Health Research (CIHR)

Eligible investigators must be:

  • Mid-career physician-scientists (MD, MD/PhD, or DO)  


  • Mid-career PhD researchers proposing collaborative projects with at least one other eligible mid-career physician-scientist


  • NEW: PhD researchers who have not yet received their first R01-level funding


For more info, CLICK HERE

2020 HTRS Mid-Career Research Award (MCRA) Recipient

Bryce A. Kerlin, MD

The 2020 MCRA was supported by a grant from Genentech, a member of the Roche Group.


2019 HTRS Mid-Career Research Award (MCRA) Recipient

Jill M. Johnsen, MD

The 2019 MCRA was supported by an educational grant from Genentech.


2017 HTRS MCRA Recipient

Shannon L. Meeks, MD
Emory University

The 2017 MCRA was supported by the Hemostasis and Thrombosis Research Society.